Edenred SE (EDNMF) reports robust intrinsic growth and strategic advancements despite regulatory impacts in key markets.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Edenred SE (EDNMF) reports robust growth in EBITDA and free cash flow, despite facing regulatory impacts in Italy and Brazil.

XRAY, EDNMY and SLVM have been added to the Zacks Rank #5 (Strong Sell) List on Nov.11, 2025

Edenred (ENXTPA:EDEN) shares have seen some ups and downs over the past month, with the stock currently down 12% in that time. Investors are paying close attention to how these shifts might reflect broader market moves or company fundamentals. See our latest analysis for Edenred. While Edenred shares have experienced a sharp pullback recently, the bigger story is that this extends an ongoing slide. The share price is down 11.9% over the last month and total shareholder return shows a steep...